Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis

Journal of Clinical Investigation

Volumn 103, Issue 7, 1999, Pages 999-1006

  Mahadeva, Ravi ^a,d   Chang, Wun Shaing W ^a,e   Dafforn, Timothy R ^a   Oakley, Diana J ^c   Foreman, Richard C ^c   Calvin, Jacqueline ^b   Wight, Derek G D ^b   Lomas, David A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALLELE; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CASE REPORT; CONFORMATIONAL TRANSITION; ENDOPLASMIC RETICULUM; ENERGY TRANSFER; GENE MUTATION; HETEROZYGOTE; HUMAN; LIVER CIRRHOSIS; MALE; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN;

EID: 0032900570     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4874     Document Type: Article

References (41)

1. Carrell, R.W., et al. 1982. Structure and variation of human α-antitrypsin. Nature. 298:329-334.
2. Brandy, M., Nukiwa, T., and Crystal, R.G. 1988. Molecular basis of alpha-1-antitrypsin deficiency. Am. J. Med. 84(Suppl. 6A):13-31.
3. 1-antitrypsin deficiency. Acta Med. Scand. Suppl. 432:1-85.
4. 1-anritrypsin deficiency: evaluation of bronchiectasis with CT. Radiology. 199:137-141.
5. 1-antitrypsin in Puerto Rican children with asthma. Chest. 103:812-815.
6. Esnault, V.L.M., et al. 1993. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int. 43:1329-1332.
7. 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int. 48:844-850.
8. 1-antitrypsin for structure and function of serpins. Biochemistry. 28:8951-8966.
9. Potempa, J., Korzus, E., and Travis, J. 1994. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269:15957-15960.
10. Johnson, D., and Travis, J. 1978. Structural evidence for methionine at the reactive site of human α-1-proteinase inhibitor. J. Biol. Chem. 253:7142-7144.
11. 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis. J. Biol. Chem. 267:1072-1080.
12. 1-antitrypsin deficiency detected by screening of 200,000 infants. N. Engl. J. Med. 294:1316-1321.
13. 1-antitrypsin deficiency. N. Engl. J. Med. 314:736-739.
14. 1-antitrypsin accumulation in the liver. Nature. 357:605-607.
15. 1-antitrypsin. Biochemistry. 32:500-508.
16. 1-antirrypsin-deficient variant with mutation on a predicted conserved residue of the serpin backbone. J. Biol. Chem. 266:12627-12632.
17. Roberts, E.A., Cox, D.W., Medline, A., and Wanless, I.R. 1984. Occurrence of alpha-1-antitrypsin deficiency in 155 patients with alcoholic liver disease. Am. J. Clin. Pathol. 82:424-427.
18. 53→Phe): further evidence for intracellular loop-sheet polymerization. J. Biol. Chem. 268:15333-15335.
19. 52Phe deleted) forms loop-sheet polymers in vivo: evidence for the C sheet mechanism of polymerization. J. Biol. Chem. 270:16864-16870.
20. 1-antitrypsin. Nat. Struct. Biol. 3:910-911.
21. 436→Thr) results in nonsubstrate-like behavior and in polymerization of the molecule. J. Biol. Chem. 268:18088-18094.
22. Eldering, E., Verpy, E., Roem, D., Meo, T., and Tosi, M. 1995. COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization. J. Biol. Chem. 270:2579-2587.
23. Bruce, D., Perry, D.J., Borg, J.-Y., Carrell, R.W., and Wardell, M.R. 1994. Thromboembolic disease due to thermolabile conformational changes of antithrombin Rouen VI (187 Asn→Asp). J. Clin. Invest. 94:2265-2274.
24. Lindo, V.S., et al. 1995. Antithrombin-TRI (Ala382 to Thr) causing severe thromboembolic tendency undergoes the S-to-R transition and is associated with a plasma-inactive high-molecular-weight complex of aggregated antithrombin. Br. J. Haematol. 89:589-601.
25. Stein, P.E., and Carrell, R.W. 1995. What do dysfunctional serpins tell us about molecular mobility and disease? Nat. Struct. Biol 2:96-113.
26. 1-antitrypsin deficiency and cirrhosis in adults, a fortuitous association. Lancet. 1:250-251.
27. 1-antitrypsin deficiency in adults with chronic active hepatitis and cryptogenic cirrhosis. N. Engl. J. Med. 304:557-560.
28. 1-antitrypsin. J. Biol. Chem. 270:5282-5288.
29. Chang, W.-S.W., Wardell, M.R., Lomas, D.A., and Carrell, R.W. 1996. Probing serpin reactive loop conformations by proteolytic cleavage. Biochem. J. 314:647-653.
30. Pemberton, P.A., Stein, P.E., Pepys, M.B., Potter, J.M., and Carrell, R.W. 1988. Hormone binding globulins undergo serpin conformational change in inflammation. Nature. 336:257-258.
31. 1-antitrypsin deficiency variants. J. Biol. Chem. 270:8393-8396.
32. 1-antitrypsin. Nat. Struct. Biol. 3:676-681.
33. 1-antitrypsin is in the canonical inhibitory conformation. J. Mol. Biol. 275:419-425.
34. 1-antitrypsin deficiency in a 4 year old girl. Helv. Paediatr. Acta. 30:501-507.
35. Campra, J.L., Craig, J.R., Peters, R.L., and Reynolds, T.B. 1973. Cirrhosis associated with partial deficiency of alpha-1-antitrypsn in an adult. Ann. Intern. Med. 78:233-238.
36. Fagerhol, M.K., and Tenfjord, D.W. 1968. Serum Pi types in some European, American, Asian and African populations. Acta Pathol. Microbiol. Scand. 72:601-608.
37. 39→Cys). Hum. Genet. 84:55-58.
38. Baur, X., and Bencze, K. 1987. Study of familial alpha-1-proteinase inhibitor deficiency including a rare proteinase inhibitor phenotype (IZ). Respiration. 51:188-195.
39. Selvin, P.R. 1995. Fluorescence resonance energy transfer. Methods Enzymol. 246:300-334.
40. Carrell, R.W., Stein, P.E., Fermi, G., and Wardell, M.R. 1994. Biological implications of a 3Å structure of dimeric antithrombin. Structure. 2:257-270.
41. 1-proteinase inhibitor probed by intrinsic tryptophan fluorescence spectroscopy. Protein Sci. 5:2226-2235.